Abbott MediaRoom (Product) http://abbott.mediaroom.com/ Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System http://abbott.mediaroom.com/2017-10-16-Patients-Battling-Complex-Regional-Pain-Syndrome-Find-a-Host-of-New-Benefits-in-Abbotts-Proclaim-TM-DRG-System - The new Proclaim™ DRG System combines the superior pain relief of dorsal root ganglion (DRG) stimulation with an intuitive iOS™ controller and programming platform for a positive patient experience Mon, 16 Oct 2017 09:00:00 -0400 http://abbott.mediaroom.com/2017-10-16-Patients-Battling-Complex-Regional-Pain-Syndrome-Find-a-Host-of-New-Benefits-in-Abbotts-Proclaim-TM-DRG-System New Data Shows That For Some Patients, Deep Brain Stimulation May Address Chronic Depression http://abbott.mediaroom.com/2017-10-11-New-Data-Shows-That-For-Some-Patients-Deep-Brain-Stimulation-May-Address-Chronic-Depression - A new dataset published in The Lancet: Psychiatry highlights the largest prospective study in DBS for chronic, treatment-resistant depression Wed, 11 Oct 2017 15:09:00 -0400 http://abbott.mediaroom.com/2017-10-11-New-Data-Shows-That-For-Some-Patients-Deep-Brain-Stimulation-May-Address-Chronic-Depression No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S. http://abbott.mediaroom.com/2017-09-27-No-More-Routine-Finger-Sticks-1-for-Americans-with-Diabetes-Abbott-s-FreeStyle-R-Libre-Approved-in-the-U-S - REVOLUTIONARY SYSTEM TO REPLACE BLOOD GLUCOSE MONITORING, ELIMINATING THE NEED FOR ROUTINE FINGER STICKS(1) AND FINGER STICK CALIBRATION Wed, 27 Sep 2017 17:42:00 -0400 http://abbott.mediaroom.com/2017-09-27-No-More-Routine-Finger-Sticks-1-for-Americans-with-Diabetes-Abbott-s-FreeStyle-R-Libre-Approved-in-the-U-S Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD http://abbott.mediaroom.com/2017-09-22-Abbott-Secures-FDA-Approval-for-MRI-Compatibility-for-the-Companys-Ellipse-TM-ICD FDA APPROVAL OF MR-CONDITIONAL LABELING FOR THE ELLIPSE™ ICD FAMILY ADDS ANOTHER PATIENT-CENTRIC BENEFIT TO A DEVICE DESIGNED TO OPTIMIZE THE TREATMENT OF ABNORMALLY FAST HEART RHYTHMS Fri, 22 Sep 2017 08:00:00 -0400 http://abbott.mediaroom.com/2017-09-22-Abbott-Secures-FDA-Approval-for-MRI-Compatibility-for-the-Companys-Ellipse-TM-ICD FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service http://abbott.mediaroom.com/2017-09-13-FreeStyle-R-Libre-Flash-Glucose-Monitoring-Technology-Gains-Reimbursement-Approval-from-the-United-Kingdoms-National-Health-Service - REVOLUTIONARY FREESTYLE® LIBRE SYSTEM ALLOWS PEOPLE WITH DIABETES TO CHECK THEIR GLUCOSE WITHOUT CALIBRATION OR ROUTINE FINGER STICKS[i] Wed, 13 Sep 2017 07:00:00 -0400 http://abbott.mediaroom.com/2017-09-13-FreeStyle-R-Libre-Flash-Glucose-Monitoring-Technology-Gains-Reimbursement-Approval-from-the-United-Kingdoms-National-Health-Service